Previous melanocortin agonists that failed clinical trials for general obesity share common features that constrain their therapeutic windows, including low receptor potency, poor safety profiles, and suboptimal pharmacokinetics
Helps to maintain and/or support cardiovascular health
These effects were associated with lowered levels of pro-inflammatory cytokines such as IL-17 and IL-23, reduced oxidative stress markers like malondialdehyde (MDA) and reactive oxygen species (ROS), and suppression of signaling pathways including PI3K and STAT3
In addition, a narrative synthesis indicated that a subgroup of Long COVID patients had elevated proinflammatory indicators and significant functional impairment
Learn how to nourish your body so you can crush your workout goals
Peptides May Be Preferred When: You want to preserve natural testosterone production and HPG axis function Fertility is a current or future concern Testosterone levels are mildly to moderately low (300-500 ng/dL) Symptoms are present but not severely impacting quality of life You prefer a therapy that works with your bodys natural systems You are interested in the additional benefits of GH optimization alongside testosterone support TRT May Be Preferred When: Testosterone levels are severely low (below 250 ng/dL) Symptoms are significantly impacting daily function and quality of life Primary hypogonadism (testicular failure) is the diagnosis, where the testes cannot respond to stimulation Faster and more predictable results from testosterone therapy are clinically important Previous peptide therapy has not produced adequate improvement In some cases, a combined approach using both peptides and TRT may be optimal
